Private Equity

Jeffrey Hollender's new book reveals the untold story of building a green empire, the pain of being fired, and the fight to keep a mission alive.

Sieve Capital launches a public campaign against Americold Chairman Mark Patterson, citing a -50% return and a history of poor corporate governance.

A Michigan senior community on the brink of failure saw a stunning financial and operational revival, culminating in a new affiliation. Here's how.

With a 30-year veteran at the helm of capital formation, ORIX USA signals a major push to scale its alternative asset platform in a competitive market.

A 78-year-old family business, Bender Plumbing Supply, joins a growing regional platform, reshaping the Northeast's competitive HVAC and plumbing market.

The national supplier's latest acquisition of a key Tennessee provider signals a major consolidation trend, raising questions about competition and local service.

As Hawaii grapples with historic floods causing over $1B in damage, Associa Cares pledges $100,000 in direct aid to displaced and affected families.

The direct-to-consumer brand hit a $100M run rate with natural supplements, attracting major investors. But do the scientific claims hold up?

New research shows parents welcome corporate sponsors in schools to fill funding gaps, creating a powerful new marketing channel built on community trust.

STRUCTURAL's purchase of The Atlantic Company signals a strategic push into the high-value historic restoration and building envelope market.

Kenon Holdings announces a $200M dividend fueled by its OPC Energy unit, whose profits soared in 2025, as it completes its strategic exit from shipping.

The Christopher Street Project’s massive rally on the National Mall united thousands to demand action and directly engage lawmakers on trans rights.

An amended deal with Tasly positions AP Biosciences to license its innovative bispecific cancer therapy to global pharma giants, targeting a lucrative market.

Dubai's AIR, owner of Al Fakher, is going public via a SPAC merger. Can it navigate a tricky market and health debates to find growth on Wall Street?

Aurinia Pharmaceuticals' deal for Kezar Life Sciences hinges on zetomipzomib, a promising but risky drug poised to tackle a rare autoimmune liver disease.

Backed by a Turkish mining giant, Capella Minerals starts crucial soil sampling in Finland's prolific gold belt, seeking the next major discovery.

The massive C$5.15 billion deal transforming Plains into a crude oil pure-play and Keyera into an NGL giant faces a delay amid a Competition Bureau review.

With a new president and a recent acquisition, Once Upon a Coconut is scaling rapidly, leveraging deep industry experience to challenge beverage giants.

Private equity firm Kain Capital backs Florida's White Wilson Medical Center, appointing a new CEO to drive expansion and a shift to value-based care.

As Houston faces a multi-billion dollar infrastructure crisis, Del Monte Capital's investment in DLG Services signals a new push to fix its aging water systems.